FDA Mulls Dramatic Shift In Generic-Drug Labeling Regs
The U.S. Food and Drug Administration is considering allowing generic-drug makers to change a product's safety warning, the agency confirmed Monday, a move that would dismantle the requirement that labeling for...To view the full article, register now.
Already a subscriber? Click here to view full article